JPH04326932A - Polyester porous film - Google Patents

Polyester porous film

Info

Publication number
JPH04326932A
JPH04326932A JP12273991A JP12273991A JPH04326932A JP H04326932 A JPH04326932 A JP H04326932A JP 12273991 A JP12273991 A JP 12273991A JP 12273991 A JP12273991 A JP 12273991A JP H04326932 A JPH04326932 A JP H04326932A
Authority
JP
Japan
Prior art keywords
copolymer
porous film
film
culture
porous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP12273991A
Other languages
Japanese (ja)
Inventor
Yoshiharu Doi
義治 土肥
Koji Kiuchi
孝司 木内
Mitsuya Ohori
大堀 満也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Nippon Zeon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zeon Co Ltd filed Critical Nippon Zeon Co Ltd
Priority to JP12273991A priority Critical patent/JPH04326932A/en
Publication of JPH04326932A publication Critical patent/JPH04326932A/en
Pending legal-status Critical Current

Links

Landscapes

  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は、3−ヒドロキシブチレ
ート単位(以下3HB成分と記す)と4−ヒドロキシブ
チレート単位を(以下4HB成分と記す)を有するポリ
エステル共重合体の多孔質フィルムに関するものである
[Field of Industrial Application] The present invention relates to a porous film of a polyester copolymer having 3-hydroxybutyrate units (hereinafter referred to as 3HB component) and 4-hydroxybutyrate units (hereinafter referred to as 4HB component). It is something.

【0002】0002

【従来の技術】近年、高分子材料による多孔質膜の研究
開発が活発に行なわれ、平膜及び中空繊維膜などの形態
に成形された多孔質膜は、透析、ろ過、ガス交換等に広
く応用されている。特に、医療分野では、人工臓器、人
工肝臓、血漿交換法、人工肺および創傷被覆材等として
その利用は急速に拡大しつつあり、これらの医療用途に
関して要求される膜の代表的性能として、生体適合性が
ある。従って、現在、生体適合性がある素材を使っての
多孔質膜の探索が急務とされている。
[Prior Art] In recent years, research and development of porous membranes made of polymeric materials has been actively carried out, and porous membranes formed in the form of flat membranes and hollow fiber membranes are widely used in dialysis, filtration, gas exchange, etc. It is applied. In particular, in the medical field, their use as artificial organs, artificial livers, plasma exchange, artificial lungs, wound dressings, etc. is rapidly expanding. Compatible. Therefore, there is currently an urgent need to search for porous membranes using biocompatible materials.

【0003】一方、微生物が作るバイオポリエステルが
優れた生体適合性材料として着目されており、近時、代
表的なバイオポリエステルであるポリ−3−ヒドロキシ
ブチレート(以下、PHBと記す)の多孔質膜の研究開
発がなされ、例えば、特開昭60−137402号公報
及び特開昭61−8107号公報にそれぞれ記載されて
いる。
On the other hand, biopolyester produced by microorganisms has attracted attention as an excellent biocompatible material, and recently, porous poly-3-hydroxybutyrate (hereinafter referred to as PHB), a typical biopolyester, has been attracting attention as an excellent biocompatible material. Research and development on membranes has been carried out, and is described, for example, in Japanese Patent Application Laid-Open Nos. 60-137402 and 61-8107, respectively.

【0004】これらの公報の多孔質膜の製造方法は、各
種有機ポリマー、オリゴマー及び粒径均一の無機塩等の
添加物を成形後溶出させたり、加熱溶融後延伸開孔し、
PHBの多孔質膜を製造するものである。
[0004] The methods for producing porous membranes disclosed in these publications include eluting additives such as various organic polymers, oligomers, and inorganic salts with uniform particle size after molding, or stretching and opening pores after heating and melting.
A porous membrane of PHB is manufactured.

【0005】しかしながら、これらの添加物溶出法およ
び加熱溶解延伸開孔法では、膜に孔を均一に配置させ、
また孔の大きさおよび形状を均一にする事は不可能であ
る。また、添加物の混在および加熱時でのポリマー変成
等の医療材料として好ましくない問題点が生じる。
[0005] However, in these additive elution methods and heat melting and stretching pore opening methods, the pores are uniformly arranged in the membrane.
Furthermore, it is impossible to make the size and shape of the holes uniform. In addition, problems that are undesirable as medical materials arise, such as mixing of additives and polymer denaturation during heating.

【0006】[0006]

【発明が解決しようとする課題】以上のような観点から
、本発明者らは、生体適合性に優れた微生物のつくるバ
イオポリエステルの多孔質膜を製造すべく鋭意研究を重
ねた結果、3HB成分および4HB成分を有するポリエ
ステル共重合体が、流延フィルム作製時の溶媒飛散速度
を調節することにより容易に多孔質膜が製造出来るとい
う全く新しい事実を見出し、この知見に基ずいて本発明
を完成するに至った。
[Problems to be Solved by the Invention] From the above points of view, the present inventors have conducted intensive research to produce a biopolyester porous membrane made by microorganisms with excellent biocompatibility. We discovered a completely new fact that a polyester copolymer having a 4HB component can be easily produced into a porous membrane by adjusting the solvent scattering rate during casting film production, and based on this knowledge, we completed the present invention. I ended up doing it.

【0007】[0007]

【課題を解決するための手段】すなわち、本発明は、3
−ヒドロキシブチレート単位と4−ヒドロキシブチレー
ト単位を有するポリエステル共重合体(以下、3HB−
4HB共重合体と記す)の溶液を流延し溶媒の飛散速度
を調整して製造される水蒸気透過性が0.5kg/m2
/24hr以上のポリエステル多孔質フィルムに関する
ものである。
[Means for Solving the Problems] That is, the present invention has three
- Polyester copolymer having hydroxybutyrate units and 4-hydroxybutyrate units (hereinafter referred to as 3HB-
The water vapor permeability produced by casting a solution of 4HB copolymer and adjusting the scattering speed of the solvent is 0.5 kg/m2.
The present invention relates to a polyester porous film that lasts for 24 hours or more.

【0008】以下、本発明を詳細に説明する。本発明の
多孔質膜の素材である3HB−4HB共重合体は、特に
制限されないが主には微生物を利用して製造される。使
用される微生物は、PHB生産能を有する微生物であれ
ば特に制限はないが、実用上は、例えば、アルカリゲネ
ス  フェカリス(  Alcaligenesfae
calis)、アルカリゲネス  ルーランデイ(Al
caligenes  ruhlandii)、アルカ
リゲネス  レイタス(Alcaligenes  l
atus)、アルカリゲネス  ユートロファス(Al
caligeneseutrophus)等のアルカリ
ゲネス属微生物などがある。
The present invention will be explained in detail below. The 3HB-4HB copolymer, which is the raw material for the porous membrane of the present invention, is mainly produced using microorganisms, although it is not particularly limited. The microorganism to be used is not particularly limited as long as it has the ability to produce PHB, but in practical terms, for example, Alcaligenes faecalis
calis), Alcaligenes roulandii (Al
caligenes ruhlandii), Alcaligenes leitus (Alcaligenes l)
atus), Alcaligenes eutrophus (Al
microorganisms of the genus Alcaligenes such as Caligenes eutrophus).

【0009】これらの微生物は、従来の方法と同様に、
主として菌体を増殖させる前段の培養と、窒素および/
もしくはリンを制御して菌体内に共重合体を生成蓄積さ
せる後段の培養の2段で培養され、本発明に使用される
共重合体が製造される。
[0009] These microorganisms can be used in the same manner as in conventional methods.
Mainly the first stage of culturing to proliferate the bacterial cells, and the nitrogen and/or
Alternatively, the copolymer used in the present invention is produced by culturing in the second stage of culture, which controls phosphorus and produces and accumulates the copolymer within the bacterial cells.

【0010】前段の培養は、微生物を培養させる為の通
常の培養法を適用する事ができる。すなわち、使用する
微生物が増殖し得る培地および培養条件を採用すればよ
い。
[0010] For the first-stage culture, a conventional culture method for culturing microorganisms can be applied. That is, it is sufficient to adopt a medium and culture conditions that allow the microorganisms used to proliferate.

【0011】培地成分は、使用する微生物が資化し得る
物質であれば特に制限はないが、実用上は、炭素源とし
ては、例えば、メタノール、エタノールおよび酢酸など
の合成炭素源、二酸化炭素などの無機炭素源、酵母エキ
ス、糖蜜、ペプトン及び肉エキスなどの天然物、アラビ
ノース、グルコース、マンノース、フラクトース、およ
びガラクトースなどの糖類ならびにソルビトール、マン
ニトールおよびイノシトールなど、窒素源としては、た
とえば、アンモニア、アンモニウム塩、硝酸塩などの無
機窒素化合物、または、尿素、コーンスチープリカー、
カゼイン、ペプトン、酵母エキス、肉エキス等の有機窒
素含有物ならびに無機成分としては、たとえば、カルシ
ウム塩、マグネシウム塩、カリウム塩、ナトリウム塩、
リン酸塩、マンガン塩、亜鉛塩、鉄塩、銅塩、モリブデ
ン塩、コバルト塩、ニッケル塩、クロム塩、ホウ素化合
物およびヨウ素化合物などからそれぞれ選択される。ま
た、必要に応じて、ビタミン類等も使用されることがで
きる。
[0011] There are no particular restrictions on the medium components as long as they can be assimilated by the microorganisms used, but in practical terms, carbon sources include synthetic carbon sources such as methanol, ethanol and acetic acid, carbon dioxide, etc. Inorganic carbon sources, natural products such as yeast extracts, molasses, peptones and meat extracts, sugars such as arabinose, glucose, mannose, fructose and galactose and nitrogen sources such as sorbitol, mannitol and inositol, such as ammonia, ammonium salts. , inorganic nitrogen compounds such as nitrates, or urea, corn steep liquor,
Examples of organic nitrogen-containing substances and inorganic components such as casein, peptone, yeast extract, and meat extract include calcium salts, magnesium salts, potassium salts, sodium salts,
The salts are selected from phosphates, manganese salts, zinc salts, iron salts, copper salts, molybdenum salts, cobalt salts, nickel salts, chromium salts, boron compounds, iodine compounds, and the like. Furthermore, vitamins and the like can also be used if necessary.

【0012】培養条件としては、温度は、例えば、20
〜40℃程度、好ましくは25〜35℃程度とされ、ま
た、pHは、たとえば、6〜10程度、好ましくは6.
5〜9.5程度とされる。このような条件で好気的に培
養する。これらの条件をはずして培養した場合には、微
生物の増殖は比較的悪くなるが、特に限定されるもので
はない。培養方法は、回分培養または連続培養のいずれ
でもよい。
[0012] As for the culture conditions, the temperature is, for example, 20°C.
The temperature is about 40°C, preferably about 25 to 35°C, and the pH is, for example, about 6 to 10, preferably 6.
It is said to be about 5 to 9.5. Cultivate aerobically under these conditions. If culture is performed outside of these conditions, the growth of microorganisms will be relatively poor, but this is not particularly limited. The culture method may be either batch culture or continuous culture.

【0013】前段の培養によって得られた培養液から微
生物の菌体を、ろ過および遠心分離のような通常の固液
分離手段により分離回収し、この菌体を後段の培養に付
するか、または、前段の培養において、窒素及び/また
はリンを実質的に枯渇させて、菌体を分離回収する事な
く、この培養液を後段の培養に移行させることによって
も出来る。
[0013] The microbial cells are separated and recovered from the culture solution obtained in the first-stage culture by ordinary solid-liquid separation means such as filtration and centrifugation, and these cells are subjected to the second-stage culture, or This can also be done by substantially depleting nitrogen and/or phosphorus in the first-stage culture and transferring this culture solution to the second-stage culture without separating and recovering the bacterial cells.

【0014】この後段の培養においては培地または培養
液に窒素および/またはリンを実質的に含有させず、ポ
リエステルの基質となる炭素源を含有させる。基質とし
て、4−ヒドロキシ酪酸、4−クロロ酪酸、4−ブロモ
酪酸等の酪酸誘導体及びそれぞれのナトリウム塩、カリ
ウム塩、マグネシウム塩、カルシウム塩、アルミニウム
塩などと、および、γ−ブチロラクトンおよび、一般式
HO(CH2)nOH(n=2、4、6、8、10、1
2) のジオール等を用い培養すると、本発明のポリエステル
多孔質フィルムの材料となる−OCH(CH3)CH2
CO−単位(3HB)と−OCH2CH2CH2CO−
 単位(4HB)を有するポリエステル共重合体が得ら
れる。
[0014] In this latter stage of culturing, the medium or culture solution is substantially free of nitrogen and/or phosphorus, but contains a carbon source that will serve as a substrate for the polyester. As substrates, butyric acid derivatives such as 4-hydroxybutyric acid, 4-chlorobutyric acid, and 4-bromobutyric acid, and their respective sodium salts, potassium salts, magnesium salts, calcium salts, aluminum salts, etc., and γ-butyrolactone and the general formula HO(CH2)nOH (n=2, 4, 6, 8, 10, 1
2) When cultured using diol etc., -OCH(CH3)CH2 becomes the material of the polyester porous film of the present invention.
CO- unit (3HB) and -OCH2CH2CH2CO-
A polyester copolymer having units (4HB) is obtained.

【0015】後段の培養条件としては、pHは6〜10
、好ましくは7〜8であり、また溶存酸素濃度は0.5
〜40ppm、好ましくは5〜20ppmである。これ
らの条件をはずして培養した場合には、乾燥菌体内に生
成蓄積するポリエステル含有量が極めて低くなり、工業
的に製造する場合には効果的でない。培養温度は、20
〜40℃程度、好ましくは25〜35℃程度である。
[0015] As for the culture conditions in the latter stage, the pH is 6 to 10.
, preferably 7 to 8, and the dissolved oxygen concentration is 0.5
-40 ppm, preferably 5-20 ppm. When culturing under these conditions, the polyester content produced and accumulated within the dried bacterial cells becomes extremely low, making it ineffective for industrial production. The culture temperature is 20
The temperature is about 40°C, preferably about 25 to 35°C.

【0016】一方、培養基質をグルコース、フルクトー
ス等の糖類及び酢酸、酪酸などの偶数カルボン酸を用い
るとPHBが得られ、培養基質をプロピオン酸、吉草酸
等の奇数カルボン酸を使用すると3HB単位と3−ヒド
ロキシバリレ−ト(3HV)とから成る共重合体(以下
、3HB−3HV共重合体と記す)が生成する。
On the other hand, if the culture substrate is a saccharide such as glucose or fructose and an even number carboxylic acid such as acetic acid or butyric acid, PHB can be obtained, and if the culture substrate is an odd number carboxylic acid such as propionic acid or valeric acid, 3HB units can be obtained. A copolymer (hereinafter referred to as 3HB-3HV copolymer) consisting of 3-hydroxyvalerate (3HV) is produced.

【0017】しかしながら、ポリマー構造が類似なこの
ような重合体の流延フィルムを製造する過程において溶
剤の飛散速度を調整しても、本発明のような多孔質フィ
ルムを得ることは出来ない。
However, even if the scattering speed of the solvent is adjusted in the process of producing a cast film of such a polymer having a similar polymer structure, it is not possible to obtain a porous film as in the present invention.

【0018】すなわち、本発明は、多孔質フィルムの材
料である3HB−4HBポリエステル共重合体と、流延
フィルムを製造する過程における溶剤の飛散速度の調整
という組合せの相乗的効果によって初めて得られる画期
的な多孔質フィルムである。用いる共重合体は、4HB
成分含量が3〜90%、好ましくは、5〜60%、さら
に好ましくは、7〜40%のものである。
That is, the present invention provides an image that can be obtained for the first time through the synergistic effect of the combination of the 3HB-4HB polyester copolymer, which is the material of the porous film, and the adjustment of the scattering speed of the solvent in the process of manufacturing the cast film. This is a revolutionary porous film. The copolymer used is 4HB
The component content is 3 to 90%, preferably 5 to 60%, more preferably 7 to 40%.

【0019】上記のようにして培養した微生物を遠心分
離等で培養液から分離し、洗浄乾燥し、クロロホルムや
アセトン等で抽出し、抽出液をn−ヘキサン等の貧溶媒
中に注ぐことによって、本発明に使用する共重合体が白
色沈殿物として得られる。
The microorganisms cultured as described above are separated from the culture solution by centrifugation, washed and dried, extracted with chloroform, acetone, etc., and the extract is poured into a poor solvent such as n-hexane. The copolymer used in the invention is obtained as a white precipitate.

【0020】このようにして得られた共重合体を溶剤に
溶かし均一な流延フィルムを製造する。流延フィルムの
製造においては任意の方法をとることが出来るが、簡単
な方法としては共重合体が溶解した溶液をガラスシャー
レなどに流し、溶剤の飛散速度を任意の方法で調節しな
がら自然乾燥する方法がある。
The copolymer thus obtained is dissolved in a solvent to produce a uniform cast film. Any method can be used to produce the cast film, but a simple method is to pour a solution in which the copolymer is dissolved into a glass petri dish, etc., and dry it naturally while adjusting the scattering speed of the solvent using any method. There is a way to do it.

【0021】溶剤の飛散速度の調整は、本発明の水蒸気
透過性が0.5kg/m2/24hr以上、好ましくは
、1.0kg/m2/24hr、更に好ましくは、3.
0kg/m2/24hr以上のポリエステル多孔質フィ
ルムが製造出来る任意の方法をとることが出来るが、簡
単な方法としては、上記の共重合体溶液を流したシャー
レに蓋をのせて調整することが出来る。特に、ポリエス
テルが析出し始める直前以降の溶媒飛散速度が早い場合
には、孔のないフィルムが出来てしまうが、遅い場合に
は、多孔質フィルムが得られ、該速度が遅いほど水蒸気
透過性の高い多孔質フィルムを得ることができる。ポリ
エステルが析出し始める直前とは、条件により異なるが
、例えば、ポリエステル濃度が約60%、好ましくは、
70%以上の状態をいう。
The scattering rate of the solvent can be adjusted so that the water vapor permeability of the present invention is 0.5 kg/m2/24 hr or more, preferably 1.0 kg/m2/24 hr, and more preferably 3.
Any method that can produce a polyester porous film of 0 kg/m2/24 hr or more can be used, but a simple method is to place a lid on a petri dish filled with the above copolymer solution. . In particular, if the solvent scattering rate immediately after the polyester begins to precipitate is fast, a film without pores will be produced, but if it is slow, a porous film will be obtained, and the slower the rate, the lower the water vapor permeability. A highly porous film can be obtained. Immediately before polyester starts to precipitate, it varies depending on the conditions, but for example, the polyester concentration is about 60%, preferably,
Refers to a condition of 70% or more.

【0022】例えば、クロロホルム等の有機溶媒に溶解
させた3〜5W/V%の3HB−4HB共重合体溶液を
入れた直径9cm程度のシャーレに蓋をして、室温で二
日以上かけて、溶媒を飛散させる。飛散時間は外温によ
って調整され、また、大スケールで行なうときは、所望
の多孔質フィルムを得るためには、予備実験が必要とな
る。
For example, a petri dish about 9 cm in diameter containing a 3-5 W/V% 3HB-4HB copolymer solution dissolved in an organic solvent such as chloroform is covered with a lid, and the mixture is heated at room temperature for two days or more. Splash the solvent. The scattering time is adjusted by the external temperature, and when carried out on a large scale, preliminary experiments are required to obtain the desired porous film.

【0023】本発明のポリエステル多孔質フィルムの製
造に用いられる溶媒は、クロロホルム、ジクロロメタン
、アセトンなどの有機溶媒が使用されるが、該ポリエス
テルを溶解するものなら、特に制限されない。溶剤の回
収などの観点から、単独溶媒が望ましいが、混合溶媒で
あっても良い。
The solvent used in the production of the polyester porous film of the present invention is an organic solvent such as chloroform, dichloromethane or acetone, but is not particularly limited as long as it dissolves the polyester. From the viewpoint of solvent recovery, a single solvent is preferable, but a mixed solvent may be used.

【0024】このようにして3HB−4HB共重合体溶
液の飛散速度を調節することで多孔質構造を有した膜に
なること、これらの孔径が溶剤の飛散速度によって調整
出来ること及びこれらの特性を有する多孔質膜が極めて
再現性よく製造できることは、本発明によってはじめて
得られた知見である。
By adjusting the scattering speed of the 3HB-4HB copolymer solution in this way, a membrane with a porous structure can be obtained, the diameter of these pores can be adjusted by the scattering speed of the solvent, and these characteristics can be improved. It is a finding obtained for the first time by the present invention that a porous membrane having the above-mentioned structure can be manufactured with extremely good reproducibility.

【0025】従来全く知られていない製法によって得ら
れる本発明の多孔質フィルムは、添加物の混入及び加熱
によるポリマー材料の変成のない医療材料に適した有用
な材料である。
The porous film of the present invention, which is obtained by a manufacturing method completely unknown heretofore, is a useful material suitable for medical materials, since it is free from mixing of additives and denaturation of the polymer material due to heating.

【0026】[0026]

【実施例】本発明を、実施例によりさらに具体的に説明
するが、本発明はこれに限定されるものではない。
EXAMPLES The present invention will be explained in more detail with reference to Examples, but the present invention is not limited thereto.

【0027】多孔質フィルム材料の3HB−4HB共重
合体の製造まず、本発明に使用する 3HB−4HB共
重合体を、菌体にアルカリゲネスユウトロファス(AT
CC17699)を使用して製造した。最初に菌体を増
殖させるための培養(前段培養)を行なうため、菌体を
次の組成を有する培地200mlを2リットルの坂口フ
ラスコに入れ、28℃で24時間培養し、遠心分離(8
000r.p.m.15分)により菌体を分離した。
Production of 3HB-4HB copolymer for porous film material First, the 3HB-4HB copolymer used in the present invention was added to the bacterial cells of Alcaligenes eutrophus (AT).
CC17699). First, in order to culture the bacterial cells to proliferate (pre-stage culture), 200 ml of a medium having the following composition was placed in a 2-liter Sakaguchi flask, cultured at 28°C for 24 hours, and then centrifuged (8
000r. p. m. 15 minutes) to separate the bacterial cells.

【0028】前段培養用培地組成(1リットル中)酵母
エキス  10g      ポリペプトン  10g
    肉エキス  5g (NH4)2SO4  5g これらを脱イオン水1リットルに溶解し、pH7.0に
調整する。
[0028] First stage culture medium composition (in 1 liter) Yeast extract 10g Polypeptone 10g
Meat extract 5g (NH4)2SO4 5g Dissolve these in 1 liter of deionized water and adjust the pH to 7.0.

【0029】上記の前段培養で得られた菌体を、以下の
組成を有する共重合体製造培地に、1リットルあたり4
gの割合で懸濁させた。この懸濁液の所定量を2リット
ルまたは500ml坂口フラスコに入れ、28℃で48
時間培養し、得られた培養液から遠心分離により、菌体
を得た。
[0029] The bacterial cells obtained in the above-mentioned first stage culture were added to a copolymer production medium having the following composition at a concentration of 4 per liter.
It was suspended in a proportion of g. Pour a predetermined amount of this suspension into a 2 liter or 500 ml Sakaguchi flask, and store at 28°C for 48 hours.
After culturing for several hours, the resulting culture solution was centrifuged to obtain bacterial cells.

【0030】共重合体製造培地の組成(1リットル中)
Na2HPO4    4.4g KH2PO4      1.2g MgSO4       0.2g 4−ヒドロキシ酪酸ナトリウム  15.0gクエン酸
ナトリウムは、表1で示した量(単位g/l)を使用し
、以上の成分を脱イオン水1リットルに溶解し、pH7
.0に調整する。
Composition of copolymer production medium (in 1 liter)
Na2HPO4 4.4g KH2PO4 1.2g MgSO4 0.2g Sodium 4-hydroxybutyrate 15.0g Sodium citrate was used in the amount shown in Table 1 (unit: g/l), and the above ingredients were mixed with 1 liter of deionized water. Dissolved in pH 7
.. Adjust to 0.

【0031】次いで菌体処理として、得られた菌体を、
蒸留水で洗浄し、これを減圧乾燥して乾燥菌体を得た。 このようにして得られた乾燥菌体から熱クロロホルムで
共重合体を抽出し、この抽出液を濃縮後大量のヘキサン
に滴下沈殿させ、この沈殿をろ取、乾燥して共重合体を
分離した。上記で得られた本発明で使用する3HB−4
HB共重合体を表1に示す。
[0031] Next, as a bacterial cell treatment, the obtained bacterial cells were
The cells were washed with distilled water and dried under reduced pressure to obtain dry bacterial cells. The copolymer was extracted from the dried bacterial cells thus obtained with hot chloroform, and this extract was concentrated and precipitated dropwise into a large amount of hexane.The precipitate was collected by filtration and dried to separate the copolymer. . 3HB-4 used in the present invention obtained above
Table 1 shows the HB copolymers.

【0032】[0032]

【表1】 共重合体  クエン酸Na        培地量  
  ポリマー収量    組成比(モル%)  番号 
     (g/l)       (ml)    
  (g/l)    3HB:4HB−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−  1              0    
      500        1.53    
    90:10−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−  2   
           0          400
        1.41        77:23
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−  3            
  0            50        
1.21        54:46−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−  4              5     
       50        1.10    
    19:81−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−− 共重合体1
および2は、2000mlの坂口フラスコ、共重合体番
号3及び4は、500mlの坂口フラスコを使用した。
[Table 1] Copolymer citrate Na medium amount
Polymer yield Composition ratio (mol%) No.
(g/l) (ml)
(g/l) 3HB:4HB------
−−−−−−−−−−−−−−−−−−−−−−−−−
--- 1 0
500 1.53
90:10------------
−−−−−−−−−−−−−−−−−−−− 2
0 400
1.41 77:23
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−− 3
0 50
1.21 54:46---------
−−−−−−−−−−−−−−−−−−−−−−−−−
-- 4 5
50 1.10
19:81------------
−−−−−−−−−−−−−−−−−− Copolymer 1
and 2 used a 2000 ml Sakaguchi flask, and copolymer numbers 3 and 4 used a 500 ml Sakaguchi flask.

【0033】また、比較例で使用するPHBは、基質に
n−酪酸を使用し、クエン酸Naを添加しない培地で、
上記と同様にして得た。3HB−3HV共重合体は、ア
ルドリッチ社製の3HV含量20モル%の共重合体を比
較例に使用した。
[0033] In addition, the PHB used in the comparative example is a medium using n-butyric acid as a substrate and without adding Na citrate.
Obtained in the same manner as above. As the 3HB-3HV copolymer, a copolymer having a 3HV content of 20 mol % manufactured by Aldrich was used in a comparative example.

【0034】多孔質フィルムの作製および水蒸気透過率
の測定上述のポリマーをクロロホルムに溶解させ、直径
9cmのガラスシャーレに流し、溶媒の飛散速度(風乾
速度)を温度およびガラスシャーレの蓋の密閉度で調整
して風乾した。作製したフィルムをシャーレより剥離さ
せ、室温で24時間真空乾燥した後、適当な大きさに切
断して水蒸気透過性の測定に使用する試験片とした。
Preparation of porous film and measurement of water vapor transmission rate The above polymer was dissolved in chloroform and poured into a glass petri dish with a diameter of 9 cm, and the scattering rate of the solvent (air drying rate) was determined depending on the temperature and the degree of sealing of the lid of the glass petri dish. Adjusted and air dried. The produced film was peeled off from the Petri dish, vacuum dried at room temperature for 24 hours, and then cut into appropriate sizes to obtain test pieces for use in measuring water vapor permeability.

【0035】水蒸気透過性は、測定サンプルビンの水蒸
気透過部の直径が12cmのサンプルビンを用い、40
℃、湿度75%の恒温恒湿槽内で、ASTM  E96
−80procedure  Aの方法により測定した
。具体的な測定手順は、以下の通りでる。 ■試験フィルムを径20〓に打抜く。 ■水蒸気透過性測定用サンプルビン(径12〓)に塩化
カルシウムを約10g入れ、試験サンプルを創面側にな
る方を上にしてセットする。 ■小数点2桁まで秤量する(W0  g)。 ■40℃、75%のインキュベーター中に入れる。 ■24時間後、再秤量し(W24  g)、下式に従っ
て水蒸気透過性を求める。水蒸気透過性(Kg/m2/
24hr)=(W24−W0)×1000/(62×π
The water vapor permeability was measured using a sample bottle with a water vapor permeable portion having a diameter of 12 cm.
℃, in a constant temperature and humidity chamber at 75% humidity, ASTM E96
-Measured by the method of 80 procedure A. The specific measurement procedure is as follows. ■Punch out the test film to a diameter of 20mm. ■Put about 10 g of calcium chloride in a sample bottle (diameter 12) for measuring water vapor permeability, and set the test sample with the wound side facing up. ■Weigh to two decimal places (W0 g). ■ Place in an incubator at 40°C and 75%. (2) After 24 hours, reweigh (W24 g) and determine water vapor permeability according to the formula below. Water vapor permeability (Kg/m2/
24hr)=(W24-W0)×1000/(62×π
)

【0036】以上の結果を表2、表3、表4、表5に
示す。
The above results are shown in Tables 2, 3, 4 and 5.

【0037】[0037]

【表2】 実施例  ポリマー濃度  注入量  風乾日数  フ
ィルム厚      水蒸気透過性         
 W/V%       ml    day    
   μm    Kg/m2/24hr  −−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−  1        3      
  45        3        280 
         2.50    −−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−  2        3        45
        4        352     
     3.49    −−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−− 
 3        3        45    
    5        390         
 3.67    −−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−  4  
      3        45        
6        438          3.8
1    −−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−  5      
  3        45      12    
    440          3.92    
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−比較例 −−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−  1        3  
      45        1        
170          0.18    −−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−  2        3      
  45        3        218 
         0.05    −−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−  3        3        45
        6        220     
     0.04    −−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−− 
 4        3        45    
    3        188         
 0.04    −−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−  5  
      3        45        
6        190          0.0
3−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−−実施例1〜5及び比較例1は
表1の共重合体2を使用し、比較例2、3のフィルムは
PHB、比較例4、5のフィルムは3HB−3HV共重
合体で作製したフィルムである。
[Table 2] Example Polymer concentration Injection amount Air drying days Film thickness Water vapor permeability
W/V% ml day
μm Kg/m2/24hr -----
−−−−−−−−−−−−−−−−−−−−−−−−−
----------- 1 3
45 3 280
2.50 -----------
−−−−−−−−−−−−−−−−−−−−−−−−−
--- 2 3 45
4 352
3.49 −−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−
3 3 45
5 390
3.67 −−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−− 4
3 45
6 438 3.8
1 −−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−− 5
3 45 12
440 3.92
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−−Comparative example −−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−−−−− 1 3
45 1
170 0.18 -----
−−−−−−−−−−−−−−−−−−−−−−−−−
----------- 2 3
45 3 218
0.05 -----------
−−−−−−−−−−−−−−−−−−−−−−−−−
--- 3 3 45
6 220
0.04 -------------
−−−−−−−−−−−−−−−−−−−−−−−−
4 3 45
3 188
0.04 −−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−− 5
3 45
6 190 0.0
3−−−−−−−−−−−−−−−−−−−−−−−−
-------------Examples 1 to 5 and Comparative Example 1 used Copolymer 2 in Table 1, the films of Comparative Examples 2 and 3 used PHB, and the films of Comparative Examples 4 and 5 is a film made of 3HB-3HV copolymer.

【0038】[0038]

【表3】 実施例  ポリマー濃度  注入量  風乾日数  フ
ィルム厚      水蒸気透過性比較例    W/
V%       ml    day       
μm    Kg/m2/24hr−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−実施例   6        3        45   
   4        330          
  3.05       比較例   6        3        45   
   1        183          
  0.22    −−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−表1の共
重合体1を使用してフィルムを作製した。
[Table 3] Example Polymer concentration Injection amount Air drying days Film thickness Water vapor permeability comparative example W/
V% ml day
μm Kg/m2/24hr------
−−−−−−−−−−−−−−−−−−−−−−−−−
--Example 6 3 45
4 330
3.05 Comparative example 6 3 45
1 183
0.22 −−−−−−−−−−−−−−
--------------------------A film was produced using Copolymer 1 shown in Table 1.

【0039】[0039]

【表4】 実施例  ポリマー濃度  注入量  風乾日数  フ
ィルム厚      水蒸気透過性比較例    W/
V%       ml    day       
μm    Kg/m2/24hr−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−実施例   7        3        13   
   7          56         
 1.01比較例   7        3        13   
   1          45         
 0.07      −−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−表1の
共重合体3を使用してフィルムを作製した。
[Table 4] Example Polymer concentration Injection amount Air drying days Film thickness Water vapor permeability comparative example W/
V% ml day
μm Kg/m2/24hr------
−−−−−−−−−−−−−−−−−−−−−−−−−
--Example 7 3 13
7 56
1.01 Comparative example 7 3 13
1 45
0.07 −−−−−−−−−−−−−
--------------------------A film was produced using Copolymer 3 in Table 1.

【0040】[0040]

【表5】 実施例  ポリマー濃度  注入量  風乾日数  フ
ィルム厚      水蒸気透過性比較例    W/
V%       ml    day       
μm    Kg/m2/24hr−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−実施例   8        2        20   
   8          63         
   0.70    比較例   8        2        20   
   1          51         
   0.03  −−−−−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−表1の共重
合体4を使用してフィルムを作製した。
[Table 5] Example Polymer concentration Injection amount Air drying days Film thickness Water vapor permeability comparative example W/
V% ml day
μm Kg/m2/24hr------
−−−−−−−−−−−−−−−−−−−−−−−−−
--Example 8 2 20
8 63
0.70 Comparative example 8 2 20
1 51
0.03 −−−−−−−−−−−−−−−
--------------------------A film was produced using Copolymer 4 in Table 1.

【0041】以上の実施例と比較例により以下のことが
分かる。表2に示される実施例と比較例の結果により、
溶剤の飛散速度が同等であっても、3HB−4HB共重
合体を使用して作製したフィルムのみが本発明の多孔質
フィルムとなり、その他のポリマーを用いたフィルムは
、本発明と同等の水蒸気透過性を有する多孔質フィルム
とならないことが理解できる。
The following points can be understood from the above examples and comparative examples. According to the results of the examples and comparative examples shown in Table 2,
Even if the solvent scattering speed is the same, only the film made using the 3HB-4HB copolymer is the porous film of the present invention, and the films made using other polymers have the same water vapor permeability as the present invention. It can be understood that this does not result in a porous film having properties.

【0042】表3、4、5に示される実施例と比較例の
結果により、3HB−4HB共重合体を使用して作製し
たフィルムであっても風乾日数が1日の場合は本発明の
多孔質フィルムとなり得ず、風乾日数が2日以上の場合
に本発明の多孔質フィルムが得られることが理解できる
According to the results of Examples and Comparative Examples shown in Tables 3, 4, and 5, even if the film was made using the 3HB-4HB copolymer, if the number of air-drying days was 1, the porous film of the present invention It can be understood that the porous film of the present invention can be obtained when the porous film is air-dried for two or more days.

【0043】また、3HB−4HB共重合体の共重合組
成や、溶液濃度、風乾日数で表わされる溶剤の飛散条件
を変えることにより、多孔質フィルムの水蒸気透過性を
制御することができ、所定の水蒸気透過性を有する多孔
性フィルムを得ることが出来る。
Furthermore, by changing the copolymerization composition of the 3HB-4HB copolymer, the solution concentration, and the solvent scattering conditions expressed by the number of air-drying days, the water vapor permeability of the porous film can be controlled, and the water vapor permeability of the porous film can be controlled to a specified level. A porous film having water vapor permeability can be obtained.

【0044】なお、本発明の多孔質フィルムの断面を電
子顕微鏡写真により観察すると、多孔質の様子を極めて
よく表わしているのが分かる。
[0044] When the cross section of the porous film of the present invention is observed using an electron micrograph, it can be seen that the porous state is very well expressed.

【0045】[0045]

【発明の効果】このように3HB−4HB共重合体溶液
の飛散速度を調節することで得られる多孔質構造を有す
るフィルムは、本発明者らの鋭意研究の結果によっても
たらされた従来全く知られていない知見によって得られ
る新規な多孔質フィルムであり、添加物の混入及び加熱
によるポリマー材料の変成のない医療材料に適した有用
な材料である。
Effects of the Invention As described above, a film having a porous structure obtained by adjusting the scattering speed of a 3HB-4HB copolymer solution has been developed as a result of intensive research by the present inventors, and is completely new to the present invention. This is a novel porous film obtained based on previously unknown knowledge, and is a useful material suitable for medical materials without mixing in additives or denaturing the polymer material due to heating.

【図面の簡単な説明】[Brief explanation of the drawing]

【図1】実施例3の多孔質フィルム断面の電子顕微鏡写
真(500倍)による多孔質の状態を表わした組織構造
写真図である。
FIG. 1 is an electron micrograph (500x magnification) of a cross section of the porous film of Example 3 showing the structure of the porous state.

【図2】実施例3の多孔質フィルム断面の電子顕微鏡写
真(2000倍)による多孔質の状態を表わした組織構
造写真図である。
FIG. 2 is an electron micrograph (2000x magnification) of a cross section of the porous film of Example 3, showing the structure of the porous state.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】  3−ヒドロキシブチレート単位と4−
ヒドロキシブチレート単位を有するポリエステル共重合
体の溶液を流延し溶媒の飛散速度を調整して製造される
水蒸気透過性が0.5kg/m2/24hr以上のポリ
エステル多孔質フィルム
[Claim 1] 3-hydroxybutyrate unit and 4-
A polyester porous film having a water vapor permeability of 0.5 kg/m2/24 hr or more, manufactured by casting a solution of a polyester copolymer having hydroxybutyrate units and adjusting the scattering speed of the solvent.
JP12273991A 1991-04-24 1991-04-24 Polyester porous film Pending JPH04326932A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12273991A JPH04326932A (en) 1991-04-24 1991-04-24 Polyester porous film

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12273991A JPH04326932A (en) 1991-04-24 1991-04-24 Polyester porous film

Publications (1)

Publication Number Publication Date
JPH04326932A true JPH04326932A (en) 1992-11-16

Family

ID=14843397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12273991A Pending JPH04326932A (en) 1991-04-24 1991-04-24 Polyester porous film

Country Status (1)

Country Link
JP (1) JPH04326932A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032536A1 (en) * 1997-12-22 1999-07-01 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6514515B1 (en) 1999-03-04 2003-02-04 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
US6610764B1 (en) 1997-05-12 2003-08-26 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6828357B1 (en) 1997-07-31 2004-12-07 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6841603B1 (en) * 1997-10-31 2005-01-11 Metabolix, Inc. Polymer blends containing polyhydroxyalkanoates and compositions with good retention of elongation
US6867248B1 (en) 1997-05-12 2005-03-15 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US7553923B2 (en) 1999-03-25 2009-06-30 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US7641825B2 (en) 2004-08-03 2010-01-05 Tepha, Inc. Method of making a polyhydroxyalkanoate filament
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10111738B2 (en) 2003-05-08 2018-10-30 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878758B2 (en) 1997-05-12 2005-04-12 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6610764B1 (en) 1997-05-12 2003-08-26 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6867248B1 (en) 1997-05-12 2005-03-15 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6828357B1 (en) 1997-07-31 2004-12-07 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6841603B1 (en) * 1997-10-31 2005-01-11 Metabolix, Inc. Polymer blends containing polyhydroxyalkanoates and compositions with good retention of elongation
EP2258742A1 (en) * 1997-12-22 2010-12-08 Metabolix, Inc. Polyhydroxyalkanoate compositons having controlled degradation rates
EP1659142A1 (en) * 1997-12-22 2006-05-24 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
EP2196484A1 (en) * 1997-12-22 2010-06-16 Metalbolix Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
WO1999032536A1 (en) * 1997-12-22 1999-07-01 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6514515B1 (en) 1999-03-04 2003-02-04 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
US6746685B2 (en) 1999-03-04 2004-06-08 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
US7553923B2 (en) 1999-03-25 2009-06-30 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US10136982B2 (en) 2003-05-08 2018-11-27 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
US10314683B2 (en) 2003-05-08 2019-06-11 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
US10111738B2 (en) 2003-05-08 2018-10-30 Tepha, Inc. Polyhydroxyalkanoate medical textiles and fibers
US7641825B2 (en) 2004-08-03 2010-01-05 Tepha, Inc. Method of making a polyhydroxyalkanoate filament
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US11426484B2 (en) 2014-08-15 2022-08-30 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US11944709B2 (en) 2014-08-15 2024-04-02 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
US10227713B2 (en) 2014-12-11 2019-03-12 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US9555155B2 (en) 2014-12-11 2017-01-31 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10590566B2 (en) 2014-12-11 2020-03-17 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
US11828006B2 (en) 2014-12-11 2023-11-28 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof

Similar Documents

Publication Publication Date Title
KR100189468B1 (en) Pha copolymer, method and microorganism producing the same
US4876331A (en) Copolyester and process for producing the same
US3044942A (en) Process for preparing poly-beta-hydroxybutyric acid
US5200332A (en) Process for preparation of copolymer
DE60200412T2 (en) Polyhydroxyalkanoate and process for its preparation, and omega (2-thienylsulfanyl) alkanoic acid and process for its preparation
JPH04326932A (en) Polyester porous film
EP0288908A2 (en) Process for production of a random copolymer comprising D-(-)-3-hydroxybutyrate units and D-(-)-3-hydroxyvalerate
US3036959A (en) Process for preparing poly-beta-hydroxy-butyric acid
US5138029A (en) Biodegradable or biocompatible copolymer and process for producing same
JPH06336523A (en) Polyester moldings
EP0416624A2 (en) Biodegradable or biocompatible copolymer and production process thereof
JP2989175B1 (en) Polyester and method for producing the same
DE60302373T2 (en) A polyhydroxyalkanoate copolymer having a bromine-containing unit in the side chain and a process for producing the same
JPH0523189A (en) Method for producing polyester copolymer
Scholz et al. Production of poly (β‐hydroxyalkanoates) with β‐substituents containing terminal ester groups by Pseudomonas oleovorans
JP2925385B2 (en) Method for producing polyhydroxy organic acid ester
JPH0714353B2 (en) Method for producing polyester copolymer
KR102728692B1 (en) Polyhydroxyalkanoates production method using Ralstonia eutropha strain
SU1375143A3 (en) Method of producing polymer containing monomeric units o. ch(ch sub three) ch sub two co
JPH0470939B2 (en)
US3121669A (en) Process for preparing poly-beta-hydroxy-butyric acid
JPH0564591A (en) Production of polyester copolymer
JPH0998793A (en) Process for producing copolyester containing 4-hydroxybutyrate unit
JPS60137402A (en) Membrane with microfine pore
JPH01222788A (en) Production of copolyester